1973
DOI: 10.1136/gut.14.1.46
|View full text |Cite
|
Sign up to set email alerts
|

Inheritance of type 2 Crigler-Najjar hyperbilirubinaemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

1976
1976
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(15 citation statements)
references
References 16 publications
0
15
0
Order By: Relevance
“…The mutation from patient B causes a 10-fold increase in the apparent Km for bilirubin when compared to expressed B-UGTI or human liver microsomes. (2)(3)(4)(5)(6)(7)(8)(9)(10). Phenobarbital response varies between 27 and 78% and serum bilirubin levels can vary between 340 and 100 1iM.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The mutation from patient B causes a 10-fold increase in the apparent Km for bilirubin when compared to expressed B-UGTI or human liver microsomes. (2)(3)(4)(5)(6)(7)(8)(9)(10). Phenobarbital response varies between 27 and 78% and serum bilirubin levels can vary between 340 and 100 1iM.…”
Section: Resultsmentioning
confidence: 99%
“…The disease is caused by an absence or strong reduction of the activity of the hepatic enzyme bilirubin UDPglucuronosyltransferase (B-UGT) (EC 2.4.1.17). The CN syndrome can be divided into two subtypes; the more severe type I with high levels of serum bilirubin and the milder type II with lower levels of serum bilirubin and a reduction of these levels of more than 30% upon phenobarbital treatment (2)(3)(4)(5)(6)(7)(8)(9)(10). Bile of type II patients contains bilirubin glucuronides, though much less than bile of healthy controls (2)(3)(4).…”
Section: Introductionmentioning
confidence: 99%
“…Based on pedigree analysis, the inheritance of CN type II has been postulated to be autosomal recessive (Blaschke et al 1974;Hunter et al 1973) or autosomal dominant with incomplete penetrance (Arias et al 1969). Gene analyses have shown both patients having recessive traits with homozygous missense mutations and a patient having dominant traits with a heterozygous nonsense mutation (Aono et al 1993;Bosma et al 1993;Koiwai et al 1996).…”
Section: Discussionmentioning
confidence: 99%
“…The hereditary transmission of the disease would be autosomal and dominant [3]. However, Hunter et al [26] recently discussed this point and suggested that the disease would be due to the transmission of two abnormal genes, one from each parent. Each one of these two genes would regulate a different stage of the UCB metabolism.…”
Section: Introductionmentioning
confidence: 99%